staurosporine has been researched along with zalcitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Antonelli, A; Cerasi, A; Columbaro, M; Falcieri, E; Luchetti, F; Magnani, M; Papa, S | 1 |
| Chevrollier, A; Jacques, C; Lagoutte, L; Loiseau, D; Malthièry, Y; Reynier, P; Savagner, F | 1 |
3 other study(ies) available for staurosporine and zalcitabine
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Programmed cell death in 2',3'-dideoxycytidine-resistant human monoblastoid U937 cells.
Topics: Anti-HIV Agents; Apoptosis; DNA; Drug Resistance; Electrophoresis, Agar Gel; Enzyme Inhibitors; Glutathione; Humans; Molsidomine; Nitric Oxide Donors; Okadaic Acid; Phosphoprotein Phosphatases; Protein Kinase Inhibitors; Staurosporine; U937 Cells; Zalcitabine | 2000 |
mtDNA controls expression of the Death Associated Protein 3.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cells, Cultured; DNA, Mitochondrial; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Ribosomal Proteins; RNA-Binding Proteins; RNA, Messenger; Staurosporine; Zalcitabine | 2006 |